Pheochromocytoma and Paraganglioma Patients with Poor Survival Often Show Brown Adipose Tissue Activation.
暂无分享,去创建一个
A. Gharib | K. Pacak | A. Civelek | D. Taïeb | A. Hamimi | A. Cypess | S. Auh | A. Jha | Melissa K. Gonzales | Alana O'mara | Sriram Gubbi | Adel Mandl | Mayank Patel | Zahraa Abdul Sater | Iris R. Hartley | I. Hartley | M. Patel | M. Gonzales | Iris R Hartley | Abhishek Jha
[1] A. Tabarin,et al. Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study. , 2019, The Journal of clinical endocrinology and metabolism.
[2] Suman Ghosal,et al. Genotype-phenotype correlations in pheochromocytoma and paraganglioma. , 2019, Endocrine-related cancer.
[3] M. Bredella,et al. Preliminary investigation of brown adipose tissue assessed by PET/CT and cancer activity , 2018, Skeletal Radiology.
[4] K. Abe,et al. FDG-PET and CT findings of activated brown adipose tissue in a patient with paraganglioma , 2018, European journal of radiology open.
[5] Alexander S. Banks,et al. Accumulation of succinate controls activation of adipose tissue thermogenesis , 2018, Nature.
[6] K. Pacak,et al. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification , 2017, Endocrine reviews.
[7] K. Pacak,et al. New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma , 2017, Trends in Endocrinology & Metabolism.
[8] P. Herscovitch,et al. Mapping of human brown adipose tissue in lean and obese young men , 2017, Proceedings of the National Academy of Sciences.
[9] C. Strassburg,et al. Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[10] Antonio L Amelio,et al. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. , 2017, Cancer cell.
[11] B. Spiegelman,et al. Cachexia and Brown Fat: A Burning Issue in Cancer. , 2016, Trends in cancer.
[12] Min Zhang,et al. Unusual FDG uptakes of mesenteric brown adipose tissue in a patient with pheochromocytomas , 2016, Nuklearmedizin.
[13] Yihai Cao,et al. Co-option of pre-existing vascular beds in adipose tissue controls tumor growth rates and angiogenesis , 2016, Oncotarget.
[14] C. A. Koch,et al. The effects of indoor and outdoor temperature on metabolic rate and adipose tissue – the Mississippi perspective on the obesity epidemic , 2016, Reviews in Endocrine & Metabolic Disorders.
[15] Felix M Mottaghy,et al. Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus , 2015, Nature Medicine.
[16] L. Gormsen,et al. Chronic adrenergic stimulation induces brown adipose tissue differentiation in visceral adipose tissue , 2015, Diabetic medicine : a journal of the British Diabetic Association.
[17] M. J. M. Llanas,et al. Case 214: Adrenal pheochromocytoma with perirenal brown fat stimulation. , 2015 .
[18] A. Doria,et al. Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. , 2015, Cell metabolism.
[19] B. Spiegelman,et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia , 2014, Nature.
[20] F. Beuschlein,et al. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. , 2014, The Journal of clinical endocrinology and metabolism.
[21] C. Zuo,et al. Hypermetabolic mesenteric brown adipose tissue on dual-time point FDG PET/CT in a patient with benign retroperitoneal pheochromocytoma. , 2014, Clinical nuclear medicine.
[22] V. Dilsizian,et al. A pilot study of FDG PET/CT detects a link between brown adipose tissue and breast cancer , 2014, BMC Cancer.
[23] F. Villarroya,et al. Beyond the sympathetic tone: the new brown fat activators. , 2013, Cell metabolism.
[24] S. Clarke,et al. Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. , 2012, Cancer research.
[25] P. Fitzgerald. Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint , 2012, Clinical epidemiology.
[26] V. Lele,et al. Unexpected visitor on FDG PET/CT--brown adipose tissue (BAT) in mesentery in a case of retroperitoneal extra-adrenal pheochromocytoma: is the BAT activation secondary to catecholamine-secreting pheochromocytoma? , 2012, Clinical nuclear medicine.
[27] A. Carpentier,et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. , 2012, The Journal of clinical investigation.
[28] P. Fitzgerald. Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer , 2009, Clinical epidemiology.
[29] J. Orava,et al. Functional brown adipose tissue in healthy adults. , 2009, The New England journal of medicine.
[30] W. D. van Marken Lichtenbelt,et al. Cold-activated brown adipose tissue in healthy men. , 2009, The New England journal of medicine.
[31] E. Palmer,et al. Identification and importance of brown adipose tissue in adult humans. , 2009, The New England journal of medicine.
[32] J. Carrasquillo,et al. Brown Fat Imaging with 18F-6-Fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECT: A Study of Patients Being Evaluated for Pheochromocytoma , 2007, Journal of Nuclear Medicine.
[33] J. Carrasquillo,et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] V. Gerbaudo,et al. Low-Dose Oral Propranolol Could Reduce Brown Adipose Tissue F-18 FDG Uptake in Patients Undergoing PET Scans , 2007, Clinical nuclear medicine.
[35] D. Murphy,et al. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. , 1986, Clinical chemistry.
[36] D. Özdemir,et al. 18F-FDG PET/CT findings in a patient with paraganglioma: Brown adipose tissue activation due to adrenergic stimulation. , 2018, Revista espanola de medicina nuclear e imagen molecular.
[37] W. D. van Marken Lichtenbelt,et al. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma. , 2016, The Journal of clinical endocrinology and metabolism.
[38] B. Spiegelman,et al. Forum Cachexia and Brown Fat : A Burning Issue in Cancer , 2016 .
[39] B. Scheithauer,et al. Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells , 2002, Endocrine pathology.